From: A PK/PD model for the evaluation of clinical rifaximin dosage for the treatment of dairy cow mastitis induced by Escherichia coli
Spiked Concentration(µg/g)
Average Recovery(%)
SD (%)
Intra RSD(%)
Inter RSD(%)
1 d
2 d
3 d
4 d
5 d
10
84.54
5.31
7.43
4.19
5.29
4.04
6.21
100
84.07
7.34
3.83
3.35
4.57
6.72
8.73
200
88.96
7.16
9.95
7.87
8.75
8.98
8.04